ClinicalTrials.Veeva

Find clinical trials for Pancreatic Cancer in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Lung Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Baltimore, MD, USA:

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions involved in th...

Active, not recruiting
Pancreatic Cancer
Drug: Nivolumab
Drug: FOLFIRINOX

Phase 2

Mass General Brigham
Mass General Brigham

Baltimore, Maryland, United States and 9 other locations

Phase 2 study to evaluate the clinical activity of INCMGA00012 in patients with Unresectable or metastatic Adenosquamous Pancreatic or Ampul....

Enrolling
Pancreatic Cancer Non-resectable
Pancreatic Cancer Metastatic
Drug: INCMGA00012 (PD-1 antibody)

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Fairfax, Virginia, United States and 89 other locations

and/or radiation, as well as patients with metastatic colorectal cancer who have exposure to 2 or more lines of chemotherapy, to evaluate sa...

Enrolling
Pancreatic Cancer
Colorectal Cancer
Drug: KRAS peptide vaccine
Drug: Nivolumab

Phase 1

Johns Hopkins Medicine
Johns Hopkins Medicine

Baltimore, Maryland, United States

The study is a first-in-human, Phase I study to assess the safety of ProAgio in participants with advanced solid tumor malignancies including pancreatic...

Enrolling
Advanced Pancreatic Cancer
Solid Tumor Malignancies
Drug: ProAgio Dose Levels (DL) 4,5,6
Drug: ProAgio Dose Levels (DL) 1,2,3

Phase 1

ProDa BioTech

Bethesda, Maryland, United States

A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...

Enrolling
Pancreatic Adenocarcinoma
Metastatic
Genetic: VCN-01
Drug: Gemcitabine

Phase 2

Theriva Biologics

Fairfax, Virginia, United States and 16 other locations

ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Phase 1, Phase 2

XBiotech

Fairfax, Virginia, United States and 27 other locations

A) vs. mFOLFIRINOX plus placebo (Arm B) in 94 subjects with advanced pancreatic cancer, not amenable to curative treatment. Both ar...

Active, not recruiting
Pancreatic Cancer
Drug: Ramucirumab
Drug: mFOLFIRINOX

Phase 2

Walid Shaib, MD

Gettysburg, Pennsylvania, United States and 7 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Fairfax, Virginia, United States and 22 other locations

Study of NGM120 in subjects with advanced solid tumors and and pancreatic cancer (Part 1 and 2) and metastatic castration resistant...

Active, not recruiting
Bladder Cancer
Esophageal Cancer
Biological: NGM120
Other: Placebo

Phase 1, Phase 2

NGM Biopharmaceuticals

Baltimore, Maryland, United States and 21 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems